The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

M1and M2 Muscarinic receptor antibodies among patients with POTS: potential disease biomarker

Discussion in 'Other Health News and Research' started by Kyla, May 29, 2016.

  1. Kyla

    Kyla ᴀɴɴɪᴇ ɢꜱᴀᴍᴩᴇʟ

    Messages:
    721
    Likes:
    4,224
    Canada
    M1and M2 Muscarinic receptor antibodies among patients with Postural Orthostatic Tachycardia Syndrome: potential disease biomarker

    Pilot study described here:
    https://www.texasneurologist.org/AM...leTypeCode=PDF&iFileName=9_Divyanshu_Abstract

    Larger replication study recruiting from Dysautonomia International conference:
    http://www.dysautonomiainternational.org/page.php?ID=240


     
    J.G, rosie26, Mrs Sowester and 9 others like this.
  2. Justin30

    Justin30 Senior Member

    Messages:
    1,065
    Likes:
    1,281
    Start the next study please:)
     
  3. Hip

    Hip Senior Member

    Messages:
    9,983
    Likes:
    16,049
    One previous study that looked for adrenergic receptor (AR) autoantibodies in POTS found α1AR antagonist autoantibodies, and β1AR & β2AR agonist autoantibodies.
     
    ScottTriGuy, Valentijn and Justin30 like this.
  4. Thinktank

    Thinktank Senior Member

    Messages:
    1,300
    Likes:
    1,485
    Europe + Asia
    Interesting, would a DMARD-agent like hydroxychloroquine then possibly benefit a subset of POTS-patients?
     
  5. Justin30

    Justin30 Senior Member

    Messages:
    1,065
    Likes:
    1,281
    I have POTS I am on Florinef......the only thing that will ever stabalize my heart rate and only usually lasts for a day is a meyers cocktail....no huge spikes nothing something is messing with vagues nerve/Autonomic nervous system
     

See more popular forum discussions.

Share This Page